RU2015156267A - Композиция для местного применения, содержащая глицерин и танин - Google Patents

Композиция для местного применения, содержащая глицерин и танин Download PDF

Info

Publication number
RU2015156267A
RU2015156267A RU2015156267A RU2015156267A RU2015156267A RU 2015156267 A RU2015156267 A RU 2015156267A RU 2015156267 A RU2015156267 A RU 2015156267A RU 2015156267 A RU2015156267 A RU 2015156267A RU 2015156267 A RU2015156267 A RU 2015156267A
Authority
RU
Russia
Prior art keywords
composition according
plant
volume
tannins
glycerol
Prior art date
Application number
RU2015156267A
Other languages
English (en)
Other versions
RU2640020C2 (ru
Inventor
Реми ШРИВАСТАВА
Леа ШРИВАСТАВА
Рави ШРИВАСТАВА
Original Assignee
Реми ШРИВАСТАВА
Леа ШРИВАСТАВА
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Реми ШРИВАСТАВА, Леа ШРИВАСТАВА filed Critical Реми ШРИВАСТАВА
Publication of RU2015156267A publication Critical patent/RU2015156267A/ru
Application granted granted Critical
Publication of RU2640020C2 publication Critical patent/RU2640020C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A01N1/0205—Chemical aspects
    • A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
    • A01N1/0221—Freeze-process protecting agents, i.e. substances protecting cells from effects of the physical process, e.g. cryoprotectants, osmolarity regulators like oncotic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/345—Alcohols containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/602—Glycosides, e.g. rutin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/13—Coniferophyta (gymnosperms)
    • A61K36/15—Pinaceae (Pine family), e.g. pine or cedar
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Environmental Sciences (AREA)
  • Zoology (AREA)
  • Dentistry (AREA)
  • Dispersion Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Physiology (AREA)
  • Botany (AREA)
  • Otolaryngology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)

Claims (15)

1. Состав для местного применения, включающий глицерин и танины растений, в котором танины растений обладают способностью связываться с глицерином так, чтобы придавать глицерину пленкообразующее свойство.
2. Состав по п. 1, в котором танины растений выбраны из проантоцианидинов.
3. Состав по п. 2, в котором проантоцианидины получен из частей растения, или целого растения, растения, выбираемого из Vaccinium myrtillus, Vaccinium macrocarpon, Vitis vinifera, European elder, Camellia sinensis, Glycine max, Acacia catechu, Fraxinus chinensis, Gingko biloba, Ribes nigrum, Tenacetum parthenium, Salix alba, Salvia officinalis, Rosmarinus officinalis, Opunitia sp., Morus alba, Rubus sp., Quercus sp, Pinus sp., Rheum emodi и их комбинаций.
4. Состав по п. 2, в котором проантоцианидины получены из частей растения, или целого растения, растения, выбираемого из Vaccinium myrtillus, Vaccinium macrocarpon, Vitis vinifera, European elder, Camellia sinensis, Glycine max и их комбинаций.
5. Состав по п. 2, в котором проантоцианидины синтезированы.
6. Состав по пп. 1-5, в котором содержание глицерина равно от 30 до 99,99% (объем/объем).
7. Состав по п. 6, дополнительно включающий активный ингредиент.
8. Состав по п. 7, в котором активный ингредиент выбран из лекарственного средства, антибиотика, антисептика, питательного вещества, антитела, фактора роста или белка.
9. Применение состава по пп. 1-8 для лечения инфекций кожи и слизистой оболочки.
10. Применение состава по пп. 1-8 для защиты, транспортировки, хранения или замораживания клеток, тканей или органов.
11. Применение по п. 10, при котором общая концентрация пленкообразующего глицерина в конечном растворе варьирует между 2-50% (объем/объем), предпочтительно, между 10-30% (объем/объем) и более предпочтительно между 15-20% (объем/объем).
12. Способ увеличения времени удержания глицериновой пленки на биологической поверхности путем приготовления раствора глицерина и танинов растений, обладающих способностью связываться с молекулами глицерина, и нанесения раствора на биологическую поверхность.
13. Способ лечения инфекций кожи и слизистой оболочки, включающий стадию нанесения состава по любому из пп. 1-8 на пораженный участок.
14. Способ получения пленкообразующего глицерина, включающий смешивание глицерина или раствора полиола с глицерин-связывающими танинами растений.
15. Способ по п. 14, в котором танины растений добавляют в виде порошка или жидкости.
RU2015156267A 2013-06-07 2013-06-07 Композиция для местного применения, содержащая глицерин и танин RU2640020C2 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2013/061835 WO2014194966A1 (en) 2013-06-07 2013-06-07 Composition for topical application comprising glycerol and tannins

Publications (2)

Publication Number Publication Date
RU2015156267A true RU2015156267A (ru) 2017-07-13
RU2640020C2 RU2640020C2 (ru) 2017-12-25

Family

ID=48652017

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2015156267A RU2640020C2 (ru) 2013-06-07 2013-06-07 Композиция для местного применения, содержащая глицерин и танин

Country Status (15)

Country Link
US (2) US9597298B2 (ru)
EP (1) EP3003380B1 (ru)
JP (1) JP2016520626A (ru)
KR (1) KR20160018648A (ru)
CN (1) CN105377300A (ru)
AU (1) AU2013391738B2 (ru)
BR (1) BR112015030543B8 (ru)
CA (1) CA2913489C (ru)
ES (1) ES2917425T3 (ru)
HK (1) HK1222538A1 (ru)
IL (1) IL242707B (ru)
MX (1) MX2015016585A (ru)
RU (1) RU2640020C2 (ru)
WO (1) WO2014194966A1 (ru)
ZA (1) ZA201508581B (ru)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10342891B2 (en) * 2013-09-19 2019-07-09 Medline Industries, Inc. Wound dressing containing saccharide and collagen
CA2974200A1 (en) * 2015-02-09 2016-08-16 The Procter & Gamble Company Cleaning and/or treatment compositions
BR112019006765B1 (pt) * 2016-10-04 2023-09-26 Membrane Protective Technologies, Inc Método para congelar células e tecidos
US11389392B2 (en) 2017-06-13 2022-07-19 Mary Kay Inc. Cosmetic compositions and methods for their use in firming skin
US11701322B2 (en) 2018-03-23 2023-07-18 Mary Kay Inc. Topical compositions and methods
JP6844857B2 (ja) * 2018-05-11 2021-03-17 株式会社アカシアの樹 アカシア属樹皮由来物を含有する皮膚保湿用組成物
CN113613660B (zh) * 2019-03-29 2024-02-06 赢创运营有限公司 包含花色素苷组合物和抗病毒剂的组合制备物
WO2021119664A1 (en) 2019-12-10 2021-06-17 Mary Kay Inc. Herbal cosmetic composition for treating skin
CN113797126A (zh) 2020-06-16 2021-12-17 玫琳凯有限公司 化妆品组合物
CA3191736A1 (en) 2020-09-08 2022-03-17 Vitrobio Sas Dual acting polymers in an osmotic film for topical application to treat inflammatory diseases and cytokine release syndrome
FR3117362B1 (fr) * 2020-12-15 2024-04-19 Oreal Procédé de revêtement des matières kératiniques avec un agent de revêtement formé par liaisons hydrogène d’un polyphénol avec un composé non-ionique polyoxyalkyléné, monoet/ ou polyglycérolé
FR3134986A1 (fr) * 2022-04-28 2023-11-03 L'oreal Composition de maquillage comprenant un polyphénol, un ester de polyglycérol, au moins une matière colorante, un mono-alcool et une teneur limitée en eau, et procédé la mettant en œuvre
WO2023208802A1 (en) * 2022-04-28 2023-11-02 L'oreal Makeup processes using a polyphenol and at least one polyglycerol compound, and compositions for performing the process
FR3134985A1 (fr) * 2022-04-28 2023-11-03 L'oreal Composition de maquillage comprenant un polyphénol, un composé hydrocarboné ou siliconé polyoxyéthyléné et/ou polyoxypropyléné, un monoalcool et une teneur limitée en eau, et procédé la mettant en œuvre
FR3134970B1 (fr) * 2022-04-28 2024-03-15 Oreal Kit de maquillage des sourcils et de la peau autour des sourcils comprenant une composition anhydre filmogène et une composition de maquillage et procédé de maquillage à 3 couches
KR102517602B1 (ko) * 2022-10-31 2023-04-04 한국 한의학 연구원 포도나무 줄기 및 유래성분을 함유하는 항바이러스 조성물

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3923984A (en) * 1974-02-11 1975-12-02 Atha Beatrice Z Shelf stable multi-use composition, preparation and use
FR2768342B3 (fr) * 1997-09-12 1999-12-03 Jean Louis Masson Creme curative aux proprietes sclero-retractiles et fibrosantes sur les hemorroides
ES2216515T3 (es) 1999-06-08 2004-10-16 Naturveda Composicion no solida para aplicacion local que comprende glicerol y un extracto de alchemilla vulgaris.
JP2003238435A (ja) * 2001-12-12 2003-08-27 Dai Ichi Seiyaku Co Ltd テストステロン５α−レダクターゼ阻害剤
JP2004123622A (ja) * 2002-10-03 2004-04-22 Toyo Shinyaku:Kk 血流改善外用剤
DE20310234U1 (de) * 2003-02-18 2003-09-18 Schmitt Martin Dermale Zubereitungen
DE10358747A1 (de) * 2003-12-12 2005-07-07 Lts Lohmann Therapie-Systeme Ag Darreichungsform basierend auf vernetzten hydrophilen Polymeren
RU2287324C1 (ru) * 2005-04-29 2006-11-20 Тамази Владимирович Баззаев Мазь для лечения ожоговых ран
US20080213300A1 (en) 2005-11-01 2008-09-04 Juice Beauty Compositions for Juice-Based Treatment Serums
AU2010213244A1 (en) * 2009-02-11 2010-08-19 Heglund, A.S. A composition for buccal absorption of nicotine for the purpose of smoking cessation
EA023814B1 (ru) * 2009-08-26 2016-07-29 Гленмарк Фармасьютикалс Лтд. Способ получения полимерных композиций на основе проантоцианидина для фармацевтических форм
US20110123700A1 (en) * 2009-11-25 2011-05-26 Peththawadu Pasan Thijee Instant liquid tea concentrate
EP2640409A1 (en) * 2010-11-19 2013-09-25 Vitro-Bio Sarl A synergistic composition of plant extracts for treating skin diseases involving abnormal cell growth

Also Published As

Publication number Publication date
US9597298B2 (en) 2017-03-21
KR20160018648A (ko) 2016-02-17
JP2016520626A (ja) 2016-07-14
ES2917425T3 (es) 2022-07-08
EP3003380A1 (en) 2016-04-13
AU2013391738A1 (en) 2015-12-17
ZA201508581B (en) 2017-01-25
US10335364B2 (en) 2019-07-02
AU2013391738B2 (en) 2019-03-14
CN105377300A (zh) 2016-03-02
US20170151172A1 (en) 2017-06-01
WO2014194966A1 (en) 2014-12-11
HK1222538A1 (zh) 2017-07-07
BR112015030543B1 (pt) 2022-05-03
US20160120824A1 (en) 2016-05-05
CA2913489A1 (en) 2014-12-11
MX2015016585A (es) 2016-07-26
BR112015030543B8 (pt) 2022-05-24
RU2640020C2 (ru) 2017-12-25
BR112015030543A2 (pt) 2017-07-25
CA2913489C (en) 2019-04-30
IL242707B (en) 2019-08-29
EP3003380B1 (en) 2022-03-16

Similar Documents

Publication Publication Date Title
RU2015156267A (ru) Композиция для местного применения, содержащая глицерин и танин
Hemmati et al. Topical grape (Vitis vinifera) seed extract promotes repair of full thickness wound in rabbit
Al-Manhel et al. Effect of aqueous and alcoholic plant extracts on inhibition of some types of microbes and causing spoilage of food.
CA2816185C (en) Compositions for the treatment of peripheral ulcers of various origins
Özbucak et al. The change in ecological, anatomical and antimicrobiological properties of the medicinal plant Tilia rubra dc. subsp. Caucasica (rupr.) v. engler along an elevational gradient
Salimgandomi et al. The effect of Chitosan on antioxidant activity and some secondary metabolites of Mentha piperita L.
CN105232417B (zh) 一种含银杏叶植物提取物的抗菌组合物及其应用
RU2018138984A (ru) ЭКСТРАКТ ЛИСТЬЕВ Harungana madagascariensis ДЛЯ ПРИМЕНЕНИЯ В ЛЕЧЕНИИ УГРЕЙ И/ИЛИ ПРЕДУПРЕЖДЕНИИ ИХ ПОЯВЛЕНИЯ
Muhammad et al. Antibacterial and cytotoxic activities of Spondias pinnata (Linn. f.) Kurz fruit extract
Häsler Gunnarsdottir et al. Antioxidative and Antimicrobial Evaluation of Bark Extracts from Common European Trees in Light of Dermal Applications
WO2018094023A3 (en) Cyclic dipeptides and wound healing
HRP20220523T1 (hr) Prirodni ljekoviti spoj
KR20170033186A (ko) 친환경 항균제를 포함하는 아토피 예방 항균 물티슈
CN107693771A (zh) 含有鲶鱼体表抗菌肽和活性多糖的促进创口愈合组合物
Gurusamy et al. In vitro antioxidant potential of ethanolic contents of Eclipta alba and Wedelia chinensis
Jacob et al. In vitro pharmacological activity of the whole plant Naregamia alata.
RU2542464C1 (ru) Композиция на основе фитоэкстрактов, подавляющая чувство кворума у бактерий
KR20160025750A (ko) 풀빅산을 이용한 항균제품
RU2289412C2 (ru) Способ регенерации эпидермиса человека
Sivtseva Fungistatic activity of some yakutian wild plant extracts
Phaechamud et al. Development of soaps containing betel nut extract
LEE et al. Complex UV Protection Efficacies of Marine Plants by UV Absorption and UV Damage Recovery
Хортецька et al. STUDY OF COMPOSITION ORGANIC ACIDS IN THE LEAVES OF PLANTAGO MEDIA L. AND PLANTAGO ALTISSIMA L.
Azizian-Shermeh et al. Phytochemical investigation, antioxidant and antimicrobial activities of Seidlitzia rosmarinus L. from Sistan and Baluchestan
MX2012002190A (es) Formulacion farmaceutica herbolaria a partir de cydonia oblonga, para su uso como analgesico, antiinflamatorio, antiseptico, cicatrizante y mucoprotector, procedimientos para su preparacion y forma de aplicacion.